Skip to main content
Log in

The synergistic effects of interleukin 2 and interleukin 7 on the proliferation and autologous tumor cell lysis of tumor-associated lymphocytes

  • Published:
Biotherapy

Abstract

Interleukin-7 (IL-7) has an ability to stimulate the proliferation of pre-B cells. It has been shown that IL-7 can also activate T lymphocytes. We here demonstrate that IL-7 in combination with interleukin-2 (IL-2) can drive cell proliferation and enhance the autologous tumor cell lysis by peripheral blood mononuclear cells (PBMC) and autologous mixed lymphocyte tumor cell culture (MLTC)-derived effector cells (MLTC cells). These synergistic effects of IL-2 and IL-7 on the proliferation and the augmentation of autologous tumor cell lysis were found for both effector cells. These effects were inhibited by neutralizing antibodies to IL-2 or IL-7, and by a combination of both antibodies, significantly. In terms of phenotypical expression, CD3 positive cells comprised the vast majority of MLTC cells after culture in medium containing IL-2 and IL-7 with an increase of IL-2 receptor positive cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

CD:

cluster differentiation

IFN:

interferon

IL:

interleukin

JRU:

Japanese Reference Unit

LAK:

lymphokine activated killer

mAb:

monoclonal antibody

MLTC:

mixed lymphocyte tumor cell culture

PBMC:

peripheral blood mononuclear cells

TILs:

tumor infiltrating lymphocytes

References

  1. Namen AE, Schmierer AE, March CJ, Overell RW, Park LS, Urdal DL, Mochizuki DY. B cell precursor growth-promoting activity. Purification and characterization of a growth factor active on lymphocyte precursors. J Exp Med 1988; 167: 988–1002.

    PubMed  Google Scholar 

  2. Namen AE, Lupton S, Hjerrild K, Wignall J, Mochizuki Y, Schmierer A, Mosley B, March CJ, Urdal D, Gillis S, Cosman D, Goodwin RG. Stimulation of B-cell progenitors by cloned murine interleukin-7. Nature 1988; 339: 571–3.

    Google Scholar 

  3. Morrissey PJ, Goodwin RG, Nordan RP, Anderson D, Grabstein KH, Cosman D, Sims J, Lupton S, Acres B, Reed SG, Mochizuki D, Eisenman J, Conlon PJ, Namen AE. Recombinant interleukin 7, pre-B cell growth factor, has costimulatory activity on purified mature T cells. J Exp Med 1989; 169: 707–16.

    PubMed  Google Scholar 

  4. Conlon PJ, Morrissey PJ, Nordan RP, Grabstein KH, Prickett KS, Reed SG, Goodwin R, Cosman D, Namen AE. Murine thymocytes proliferate in direct response to interleukin-7. Blood 1989; 74: 1368–73.

    PubMed  Google Scholar 

  5. Chazen GD, Pereira GMB, LeGros G, Gillis S, Shevach EM. Interleukin 7 is a T cell growth factor. Proc Natl Acad Sci 1989; 86: 5923–7.

    PubMed  Google Scholar 

  6. Okazaki M, Ito M, Sudo T, Hattori M, Kano S, Katsura Y, Minato N. IL-7 promotes thymocyte proliferation and maintains immunocompetent thymocytes bearingαβ orγδ T-cell receptors in vitro: synergism with IL-2. J Immunol 1989; 143: 2917–22.

    PubMed  Google Scholar 

  7. Welch PA, Namen AE, Goodwin RG, Armitage R, Cooper MD. Human Il-7: a novel T cell growth factor. J Immunol 1989, 11: 3562–7.

    Google Scholar 

  8. Parks LS, Friend DJ, Schmeirer AE, Dower SK, Namen AE. Murine interleukin-7 (IL-7) receptor. Characterization on an IL-7-dependent cell line. J Exp Med 1990; 171: 1073–89.

    PubMed  Google Scholar 

  9. Anderson MR, Sassenfeld HM, Widmer MB. Interleukin 7 enhances cytolytic T lymphocyte generation and induces lymphokine activated killer cells from human peripheral blood. J Exp Med 1990; 172: 577–87.

    PubMed  Google Scholar 

  10. Uchida A, Moore M. Lysis of fresh human tumour cells by autologous large granulocytes and T-lymphocytes: two distinct killing activities induced by co-culture with autologous tumor. J Natl Cancer Inst 1984; 73: 1285–92.

    PubMed  Google Scholar 

  11. Belldegrun A, Munl LM, Rosenberg SA. Interleukin-2 expanded tumor infiltrating lymphocytes in human renal cell cancer: isolation, characterization, and antitumor activity. Cancer Res 1988; 48: 206–14.

    PubMed  Google Scholar 

  12. Dibirdik I, Langlie MC, Ledbetter JA, Tuel-Ahlgen L, Obuz V, Waddick KG, Gajl-Peczalska K, Schieven GL, Uckun FM. Engagement of interleukin-7 receptor stimulates thyrosine phosphorylation phosphoinositide turnover, and clonal proliferation of human T-lineage acute lymphoblastic leukemia cells. Blood 1991; 78: 564–70.

    PubMed  Google Scholar 

  13. Digel W, Schmid M, Heil G, Conrad P, Gillis S, Porzsolt F. Human interleukin-7 induces proliferation of neoplastic cells from chronic lymphocytic leukemia and acute leukemias. Blood 1991; 78: 753–9.

    PubMed  Google Scholar 

  14. Eder M, Ottmann OG, Hansen-Hagge TE, Bartram CR, Falk S, Gillis S, Hoelzer D, Ganser A. In vitro culture of common acute lymphoblastic leukemia blasts: effects of interleukin-3, interleukin-7, and accessory cells. Blood 1992; 79: 3274–84.

    PubMed  Google Scholar 

  15. Stotter H, Custer MC, Bolton ES, Guedez L, Lotze MT. IL-7 induces human lymphokine-activated killer cell activity and is regulated by IL-4. J Immunol 1991; 146: 150–5.

    PubMed  Google Scholar 

  16. Ditonno P, Tso CL, Dekernion JB, Belldegrum A. Regulatory effects of interleukin-7 on renal tumor infiltrating lymphocytes. Urol Res 1992; 20: 205–10.

    PubMed  Google Scholar 

  17. Lotze MT, Ieh HJ III, Elder EM, Cai Q, Pippin BA, Rosenstein MM, Whiteside TL, Herbermann R. Use of T-cell growth factors (interleukin 2, 4, 7, 10, and 12) in the evaluation of T-cell reactivity to melanoma. J Immunol 1992; 12: 212–7.

    Google Scholar 

  18. Armitage RJ, Namen AE, Sassenfeld HM, Grabstein KH. Regulation of human T cell proliferation by IL-7. J Immunol 1990; 144: 938–41.

    PubMed  Google Scholar 

  19. Yoshioka R, Shimizu S, Tachibana J, Hirose Y, Fukutoku M, Takeuchi Y, Sugai S, Takiguchi T, Konda S. Interleukin-7 (IL-7)-induced proliferation of CD8+ T-chronic lymphocytic leukemia cells. J Clin Immunol 1992; 12: 101–6.

    PubMed  Google Scholar 

  20. Maraskovsky E, Chen WF, Shortman K, IL-2 and IFN-γ are two necessary lymphokines in the development of cytolytic T cells. J Immunol 1989; 143: 1210–4.

    PubMed  Google Scholar 

  21. Lynch DH, Namen AE, Miller RE. In vivo evaluation of the effects of the interleukin 2, 4 and 7 on enhancing the immunotherapeutic efficacy of anti-tumor cytotoxic T lymphocytes. Eur J Immunol 1991; 21: 2977–85.

    PubMed  Google Scholar 

  22. Jicha DL, Mule JJ, Rosenberg SA. Interleukin 7 generates antitumor cytotoxic T lymphocytes against murine sarcomas with efficacy in cellular adoptive immunotherapy. J Exp Med 1991; 174: 1511–5.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tsukuda, M., Mochimatsu, I., Sakumoto, M. et al. The synergistic effects of interleukin 2 and interleukin 7 on the proliferation and autologous tumor cell lysis of tumor-associated lymphocytes. Biotherapy 6, 167–174 (1993). https://doi.org/10.1007/BF01878077

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01878077

Key words

Navigation